Relevance of CYP17A1 Blockade in Clones of Castration-resistant Prostate Cancer

被引：0
|
作者：
Kumagai, J. [1 ]
Erkens-Schulze, S. [2 ]
Dits, N. F. J. [2 ]
de Wit, R. [3 ]
van Weerden, W. M. [1 ]
机构：
[1] Univ Tokyo, Tokyo, Japan
[2] Erasmus MC, Rotterdam, Netherlands
[3] Erasmus MC, Med Oncol, Rotterdam, Netherlands
来源：
EUROPEAN JOURNAL OF CANCER | 2012年 / 48卷
关键词：
D O I：
10.1016/S0959-8049(12)72094-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
296
引用
收藏
页码：90 / 91
页数：2
相关论文
共 50 条
  • [21] Targeted Inhibition of CYP11A1 in Castration-Resistant Prostate Cancer
    St-Laurent, Marie-Pier
    Black, Peter C.
    EUROPEAN UROLOGY, 2024, 86 (02) : 185 - 186
  • [22] Genetic polymorphisms of CYP17A1 in steroidogenesis pathway are associated with risk of progression to castration-resistant prostate cancer in Japanese men receiving androgen deprivation therapy
    Takeshi Yamada
    Masashi Nakayama
    Tomohito Shimizu
    Shinpei Nonen
    Yasutomo Nakai
    Kazuo Nishimura
    Yasushi Fujio
    Akihiko Okuyama
    Junichi Azuma
    Norio Nonomura
    International Journal of Clinical Oncology, 2013, 18 : 711 - 717
  • [23] Efficacy of androgen signaling blockade in castration-resistant prostate cancer
    Nature Clinical Practice Urology, 2008, 5 (10): : 523 - 524
  • [24] Discovery and development of ODM-204: A Novel nonsteroidal compound for the treatment of castration-resistant prostate cancer by blocking the androgen receptor and inhibiting CYP17A1
    Oksala, Riikka
    Moilanen, Anu
    Riikonen, Reetta
    Rummakko, Petteri
    Karjalainen, Arja
    Passiniemi, Mikko
    Wohlfahrt, Gerd
    Taavitsainen, Paivi
    Malmstrom, Chira
    Ramela, Meri
    Metsankyla, Hanna-Maija
    Huhtaniemi, Riikka
    Kallio, Pekka J.
    Mustonen, Mika V. J.
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2019, 192
  • [25] Genetic polymorphisms of CYP17A1 in steroidogenesis pathway are associated with risk of progression to castration-resistant prostate cancer in Japanese men receiving androgen deprivation therapy
    Yamada, Takeshi
    Nakayama, Masashi
    Shimizu, Tomohito
    Nonen, Shinpei
    Nakai, Yasutomo
    Nishimura, Kazuo
    Fujio, Yasushi
    Okuyama, Akihiko
    Azuma, Junichi
    Nonomura, Norio
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2013, 18 (04) : 711 - 717
  • [26] ODM-204: A novel dual inhibitor of CYP17A1 and androgen receptor for the treatment of castration-resistant prostate cancer-Preclinical data.
    Oksala, Riikka
    Moilanen, Anu
    Riikonen, Reetta
    Rummakko, Petteri
    Huhtaniemi, Riikka
    Kallio, Pekka
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [27] Increased expression of CYP17A1 indicates an effective targeting of the androgen receptor axis in castration resistant prostate cancer (CRPC)
    Bremmer, Felix
    Jarry, Hubertus
    Strauss, Arne
    Behnes, Carl Ludwig
    Trojan, Lutz
    Thelen, Paul
    SPRINGERPLUS, 2014, 3
  • [28] Synthesis of Fluorinated Analogs of Abiraterone, a Mechanism-based Inhibitor of CYP17A1 for Castration Resistant Prostate Cancer Therapy
    Veach, Darren R.
    Evans, Michael
    Sawyers, Charles L.
    Larson, Steven M.
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2011, 54 : S227 - S227
  • [29] Transcriptomic features of primary prostate cancer and their prognostic relevance to castration-resistant prostate cancer
    Yun, Seok Joong
    Kim, Seon-Kyu
    Kim, Jayoung
    Cha, Eun-Jong
    Kim, Jang-Seong
    Kim, Sun-Jin
    Ha, Yun-Sok
    Kim, Ye-Hwan
    Jeong, Pildu
    Kang, Ho Won
    Kim, Jeong-Hwan
    Park, Jong-Lyul
    Choi, Young-Ki
    Moon, Sung-Kwon
    Choi, Yung-Hyun
    Kim, Seon-Young
    Kim, Wun-Jae
    ONCOTARGET, 2017, 8 (70) : 114845 - 114855
  • [30] DIETHYLSTILBESTROL IN CASTRATION-RESISTANT PROSTATE CANCER OESTROGENS IN CASTRATION-RESISTANT PROSTATE CANCER: BACK TO THE FUTURE?
    Sartor, Oliver
    BJU INTERNATIONAL, 2012, 110 (11B) : E736 - E736
12345